什么是杠杆股票交易-看股市财经评论什么软件好-【东方资本】,手机炒股开户怎么开户流程视频,股票上午卖下午能取钱吗,otc证券开户条件

"Biodegradable coronary stents (xinsorb)" is a project independently developed by our company. The core of the project is new material research and application technology, involving biopharmaceutical research, solid mechanics research, medical clinical experiment and the production of implantable medical devices.

After eight years of hard work, we have overcome many technical difficulties and mastered the core technology of only a few companies in the world. We have successfully developed the "biodegradable coronary rapamycin eluting stent system" (xinsorb stent), which is the first in China and has the world leading level. The fourth development of percutaneous coronary intervention is known as the fourth development of bare metal stent.